LifeMine Therapeutics
LifeMine Therapeutics is a clinical-stage biopharmaceutical company headquartered in Watertown, Massachusetts, with sites in Gloucester, Massachusetts and Basel, Switzerland. It pioneers a Top-Down Drug Discovery approach that leverages evolutionary insights from fungi to find next-generation precision medicines. Its LifeBank collection of deep-sequenced wild-type fungi and its Avatar-Rx platform combine human genetics and genomics, bioinformatics, machine learning and synthetic biology to mine biosynthetic gene clusters for genetically encoded small molecules, using embedded target genes as avatars to predict therapeutic effect independent of chemical structure. Its lead program LIFE-001 is a precision-engineered calcineurin inhibitor in Phase 1 for immune-mediated disorders and organ transplant rejection, alongside a genomic drug discovery alliance with GSK. LifeMine publishes no public API, developer portal, or machine-readable API specification.
LifeMine Therapeutics is profiled on the APIs.io network. Tagged areas include Company, Life Sciences, Biotechnology, Drug Discovery, and Genomics.
LifeMine Therapeutics’ developer surface includes engineering blog, product news, and 8 more developer resources.
Kin Score
Security Posture 1
Authentication, domain security, vulnerability disclosure, and trust-center signals.
Resources
Agent Surfaces 1
MCP servers, agent skills, and machine-readable catalogs
Access & Security 1
Authentication, authorization, and security posture
Operate 1
Status, limits, changes, and where to get help
Commercial 1
Pricing, plans, and the legal terms of use
Company 6
The organization behind the API